LT2450057T - Naujos cddo metilo esterio formos - Google Patents

Naujos cddo metilo esterio formos

Info

Publication number: LT2450057T
Authority: LT; Lithuania
Prior art keywords: methyl ester; novel forms; cddo methyl; cddo; novel
Prior art date: 2007-08-15

Application number

LTEP12153605.6T

Other languages

English (en)

Inventor

John Walling

Stephan D. Parent

David T. Jonaitis

Original Assignee

Reata Pharmaceuticals, Inc.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-08-15

Filing date

2008-08-14

Publication date

2016-12-27

2008-08-14 Application filed by Reata Pharmaceuticals, Inc. filed Critical Reata Pharmaceuticals, Inc.

2016-12-27 Publication of LT2450057T publication Critical patent/LT2450057T/lt

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J63/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms
- C07J63/008—Expansion of ring D by one atom, e.g. D homo steroids

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Molecular Biology (AREA)
Epidemiology (AREA)
Immunology (AREA)
Psychiatry (AREA)
Rheumatology (AREA)
Psychology (AREA)
Pain & Pain Management (AREA)
Hospice & Palliative Care (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Steroid Compounds (AREA)
Medicines Containing Plant Substances (AREA)
Glass Compositions (AREA)

LTEP12153605.6T 2007-08-15 2008-08-14 Naujos cddo metilo esterio formos LT2450057T (lt)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US95593907P	2007-08-15	2007-08-15

Publications (1)

Publication Number	Publication Date
LT2450057T true LT2450057T (lt)	2016-12-27

Family

ID=40351005

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
LTEP12153605.6T LT2450057T (lt)	2007-08-15	2008-08-14	Naujos cddo metilo esterio formos

Country Status (28)

Country	Link
US (3)	US8088824B2 (lt)
EP (2)	EP2450057B1 (lt)
JP (4)	JP5005812B2 (lt)
KR (2)	KR101481764B1 (lt)
CN (2)	CN101820758B (lt)
AR (2)	AR073155A1 (lt)
AT (1)	ATE549035T1 (lt)
AU (1)	AU2008287388B2 (lt)
BR (1)	BRPI0815540A8 (lt)
CA (2)	CA2871864C (lt)
CL (1)	CL2008002417A1 (lt)
CY (2)	CY1112864T1 (lt)
DK (2)	DK2187741T3 (lt)
EA (2)	EA018704B1 (lt)
ES (2)	ES2382571T3 (lt)
HR (2)	HRP20120350T1 (lt)
HU (1)	HUE031866T2 (lt)
IL (2)	IL203824A (lt)
LT (1)	LT2450057T (lt)
MX (1)	MX2010001628A (lt)
NZ (1)	NZ583269A (lt)
PL (2)	PL2187741T3 (lt)
PT (2)	PT2450057T (lt)
SG (2)	SG177905A1 (lt)
SI (2)	SI2187741T1 (lt)
TW (2)	TWI486357B (lt)
WO (1)	WO2009023232A1 (lt)
ZA (1)	ZA201001066B (lt)

Families Citing this family (55)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6326507B1 (en) *	1998-06-19	2001-12-04	Trustees Of Dartmouth College	Therapeutic compounds and methods of use
US7435755B2 (en)	2000-11-28	2008-10-14	The Trustees Of Dartmouth College	CDDO-compounds and combination therapies thereof
AU2003235676A1 (en)	2002-01-15	2003-07-30	Trustees Of Dartmouth College	Tricyclic-bis-enone derivatives and methods of use thereof
WO2008064132A2 (en)	2006-11-17	2008-05-29	Trustees Of Dartmouth College	Synthetic triterpenoids and tricyclic-bis-enones for use in stimulating bone and cartilage growth
US8921340B2 (en)	2006-11-17	2014-12-30	Trustees Of Dartmouth College	Methods for using synthetic triterpenoids in the treatment of bone or cartilage diseases or conditions
CA2670099A1 (en)	2006-11-17	2008-05-29	Trustees Of Dartmouth College	Synthesis and biological activities of new tricyclic-bis-enones (tbes)
US8088824B2 (en) *	2007-08-15	2012-01-03	Reata Pharmaceuticals Inc.	Forms of CDDO methyl ester
LT2252283T (lt) *	2008-01-11	2019-03-25	Reata Pharmaceuticals, Inc.	Sintetiniai triterpenoidai ir jų panaudojimo būdai gydant ligą
CN103588678A (zh)	2008-04-18	2014-02-19	里亚塔医药公司	包含抗炎症药效团的化合物以及使用方法
LT2271658T (lt)	2008-04-18	2017-02-27	Reata Pharmaceuticals, Inc.	Antioksidantai uždegimo moduliatoriai:oleanolio rūgšties c-17 patvirtinti dariniai
JP5529851B2 (ja)	2008-04-18	2014-06-25	リアタファーマシューティカルズインコーポレイテッド	抗酸化炎症モジュレーター：ｃ−１７においてアミノ改変およびその他の改変を加えたオレアノール酸誘導体
WO2009146216A2 (en)	2008-04-18	2009-12-03	Reata Pharmaceuticals. Inc.	Antioxidant inflammation modulators: novel derivatives of oleanolic acid
EA022588B1 (ru)	2008-04-18	2016-01-29	Ритэ Фамэсутикл, Инк.	Антиоксидантные модуляторы воспаления: производные олеанолевой кислоты с насыщением в с-кольце
US8314137B2 (en)	2008-07-22	2012-11-20	Trustess Of Dartmouth College	Monocyclic cyanoenones and methods of use thereof
US8747901B2 (en) *	2009-02-13	2014-06-10	Reata Pharmaceuticals, Inc.	Delayed release, oral dosage compositions that contain amorphous CDDO-Me
US8759535B2 (en)	2010-02-18	2014-06-24	High Point Pharmaceuticals, Llc	Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof
CN102762101B (zh)	2010-02-18	2014-09-17	高点制药有限责任公司	取代的稠合咪唑衍生物、药物组合物及其使用方法
MY163031A (en)	2010-04-12	2017-07-31	Reata Pharmaceuticals Inc	Method of treating obesity using antioxidant inflammation modulators
HRP20171859T1 (hr)	2010-12-17	2018-01-26	Reata Pharmaceuticals, Inc.	Pirazolil i pirimidinil triciklički enoni kao antioksidacijski modulatori upale
SMT201900433T1 (it)	2011-03-11	2019-09-09	Reata Pharmaceuticals Inc	Derivati di c4-monometil triterpenoidi e metodi del loro uso
CN103156861B (zh) *	2011-12-08	2015-11-25	陈丽梅	齐敦果酸衍生物及其可药用盐在治疗糖尿病眼病中的应用
LT2841445T (lt)	2012-04-27	2017-09-11	Reata Pharmaceuticals, Inc.	Bardoksolonmetilo 2,2-difluorpropionamido dariniai, polimorfinės formos ir jų panaudojimo būdai
US8981144B2 (en)	2012-05-08	2015-03-17	Trustees Of Dartmouth College	Method for synthesizing 2-cyano-3,12-dioxoolean-1, 9(11)-dien-28-oic acid methyl ester and derivatives thereof
US8921419B2 (en)	2012-05-08	2014-12-30	Trustees Of Dartmouth College	Triterpenoids and compositions containing the same
US9556222B2 (en)	2012-06-15	2017-01-31	Reata Pharmaceuticals, Inc.	A-ring epoxidized triterpenoid-based anti-inflammation modulators and methods of use thereof
US9512094B2 (en)	2012-09-10	2016-12-06	Reata Pharmaceuticals, Inc.	C17-heteroaryl derivatives of oleanolic acid and methods of use thereof
WO2014040073A1 (en)	2012-09-10	2014-03-13	Reata Pharmaceuticals, Inc.	C13-hydroxy derivatives of oleanolic acid and methods of use thereof
MY180903A (en)	2012-09-10	2020-12-11	Reata Pharmaceuticals Inc	C17-alkanediyl and alkenediyl derivatives of oleanolic acid and methods of use thereof
CN104936972A (zh) *	2012-09-10	2015-09-23	艾伯维公司	具有抗炎活性的甘草次酸衍生物
JP5972986B2 (ja)	2012-09-28	2016-08-17	アプライドファーマシューティカルサイエンスインコーポレイテッド	Ｃｄｄｏエチルエステルの多形体及びその用途
CN102875634B (zh) *	2012-10-24	2014-08-20	苏州晶云药物科技有限公司	2-氰基-3,12-二氧代齐墩果-1,9(11)-二烯-28-酸甲酯的几种晶型
CN102887936A (zh) *	2012-10-24	2013-01-23	苏州晶云药物科技有限公司	2-氰基-3,12-二氧代齐墩果-1,9(11)-二烯-28-酸甲酯晶型
US9796752B2 (en)	2013-03-19	2017-10-24	Daiichi Sankyo Company, Limited	Terpenoid derivatives
UY39092A (es)	2013-04-24	2021-03-26	Abbvie Inc	Derivados de 2,2-difluoropropanamida y metil bardoxolona, formas polimórficas y métodos de uso
WO2015027206A1 (en) *	2013-08-23	2015-02-26	Reata Pharmaceuticals, Inc.	Methods of treating and preventing endothelial dysfunction using bardoxololone methyl or analogs thereof
US10189791B2 (en)	2014-08-26	2019-01-29	Trustees Of Dartmouth College	Pyridyl analogs of 1-(2-cyano-3,12-dioxooleana-1,9(11)dien-28-oyl) imidazole
US9896475B2 (en)	2014-08-26	2018-02-20	Trustees Of Dartmouth College	Pyridyl analogs of 1-(2-cyano-3,12-dioxooleana-1,9(11)dien-28-oyl) imidazole
EP3192875B1 (en)	2014-09-10	2019-12-18	Daiichi Sankyo Company, Limited	Sustained-release pharmaceutical composition for treating and preventing ophthalmic diseases
WO2016089648A1 (en)	2014-12-01	2016-06-09	Vtv Therapeutics Llc	Bach 1 inhibitors in combination with nrf2 activators and pharmaceutical compositions thereof
US11591302B2 (en)	2014-12-19	2023-02-28	Geistlich Pharm A Ag	Processes for preparing oxathiazin-like compounds
WO2016098054A1 (en)	2014-12-19	2016-06-23	Geistlich Pharma Ag	Processes for preparing oxathiazin-like compounds
CN107428698B (zh)	2015-02-12	2021-10-26	里亚塔医药公司	作为抗氧化炎症调节剂的咪唑基三环烯酮
PL3317281T3 (pl) *	2015-07-02	2020-11-02	Acerta Pharma B.V.	Postacie stałe i formulacje (s)-4-(8-amino-3-(1-(but-2-ynoilo)pirolidyn-2-ylo)imidazo[1,5-a]-pirazyn-1-ylo)-n-(pirydyn-2-ylo)benzamidu
NZ741082A (en)	2015-09-23	2023-06-30	Reata Pharmaceuticals Inc	C4-modified oleanolic acid derivatives for inhibition of il-17 and other uses
NZ753546A (en) *	2016-11-08	2022-10-28	Reata Pharmaceuticals Holdings Llc	Methods of treating alport syndrome using bardoxolone methyl or analogs thereof
TWI831738B (zh)	2016-12-16	2024-02-11	美商瑞塔醫藥有限責任公司	用於抑制ＲＯＲγ及其他用途的嘧啶三環烯酮衍生物
EP3652193A1 (en)	2017-07-13	2020-05-20	Pliva Hrvatska D.O.O.	New crystalline polymorphs of bardoxolone methyl
JP7244536B2 (ja)	2018-04-06	2023-03-22	キャプシュゲル・ベルジウム・エヌ・ヴィ	メタクリル酸メチル－メタクリル酸コポリマーからなる低アスペクト比の粒子のための噴霧乾燥方法
MX2020013692A (es)	2018-06-15	2021-02-26	Reata Pharmaceuticals Inc	Compuestos de pirazol e imidazol para la inhibicion de il-17 y rorgamma.
WO2019246461A1 (en)	2018-06-20	2019-12-26	Reata Pharmaceuticals, Inc.	Cysteine-dependent inverse agonists of nuclear receptors ror-gamma/ror-gamma-t and methods of treating diseases or disorders therewith
JPWO2020111089A1 (ja)	2018-11-27	2021-10-14	協和キリン株式会社	医薬組成物
CA3249188A1 (en)	2019-07-19	2025-06-05	Reata Pharmaceuticals, Inc.	C17 Polar Substitution Hetero-Romatic Synthetic Triterpenoids and Their Methods of Use
CA3177913A1 (en)	2020-05-09	2021-11-18	Deborah FERGUSON	Methods of treating covid-19 using bardoxolone methyl or analogs thereof
US12059419B2 (en)	2020-10-16	2024-08-13	Idience Co., Ltd.	Pharmaceutical composition comprising phthalazinone derivatives
AU2021397631A1 (en)	2020-12-11	2023-07-20	Reata Pharmaceuticals Holdings, LLC	Synthetic triterpenoids for use in therapy

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPH07121911B2 (ja) *	1986-03-26	1995-12-25	クミアイ化学工業株式会社	４（１ｈ）−ピリジノン誘導体および農園芸用殺菌剤
JPH01273020A (ja) *	1988-04-26	1989-10-31	Toray Ind Inc	有機非線形光学材料
US5064823A (en)	1988-08-24	1991-11-12	Research Triangle Institute	Pentacyclic triterpenoid compounds as topoisomerase inhibitors or cell differentiation inducers
JP2876144B2 (ja) *	1990-03-23	1999-03-31	東洋フアルマー株式会社	３―フェニルクマリン―７―イルオキシ酢酸誘導体とその製法及び用途
GB9622173D0 (en) *	1996-10-24	1996-12-18	Glaxo Group Ltd	Particulate Products
US20050276836A1 (en)	1997-06-11	2005-12-15	Michelle Wilson	Coated vaginal devices for vaginal delivery of therapeutically effective and/or health-promoting agents
US6326507B1 (en)	1998-06-19	2001-12-04	Trustees Of Dartmouth College	Therapeutic compounds and methods of use
US6890946B2 (en) *	1999-12-23	2005-05-10	Indiana University Research And Technology Corporation	Use of parthenolide to inhibit cancer
US7435755B2 (en)	2000-11-28	2008-10-14	The Trustees Of Dartmouth College	CDDO-compounds and combination therapies thereof
CA2430454A1 (en) *	2000-11-28	2002-06-20	Board Of Regents, The University Of Texas System	Cddo-compounds and combination therapies thereof
CA2485565A1 (en) *	2002-05-13	2004-08-05	Trustees Of Dartmouth College	Inhibitors and methods of use thereof
JP3618341B2 (ja) *	2003-04-15	2005-02-09	山之内製薬株式会社	臭化物及びその結晶
FR2861299B1 (fr) *	2003-10-28	2006-01-27	Pf Medicament	Compositions pharmaceutiques a base de derives d'idasoxan sous formes polymorphes
WO2005057275A1 (ja)	2003-12-08	2005-06-23	Sony Corporation	液晶表示装置およびバックライト調整方法
US20060167097A1 (en) *	2004-04-16	2006-07-27	Cheppail Ramachandran	Compositions and uses of Amooranin compounds
EP1904480A2 (en) *	2005-05-23	2008-04-02	Novartis Pharma AG	Crystalline and other forms of 4-amino-5-fluoro-3-[6-(4-methylpiperazin-1-yl)-1h-benzimidazol-2-yl]-1h-quinolin-2-one lactic acid salts
DE102005041613A1 (de)	2005-09-01	2007-03-08	Ergonex Pharma Gmbh	Pharmazeutische Zusammensetzungen zur Behandlung von Karzinoid-Syndrom
AU2006325586B2 (en)	2005-12-12	2013-01-31	Mosamedix B.V.	Annexin derivatives suitable for pretargeting in therapy and diagnosis
US8088824B2 (en) *	2007-08-15	2012-01-03	Reata Pharmaceuticals Inc.	Forms of CDDO methyl ester

2008
- 2008-08-13 US US12/191,176 patent/US8088824B2/en active Active
- 2008-08-14 WO PCT/US2008/009703 patent/WO2009023232A1/en not_active Ceased
- 2008-08-14 SI SI200830650T patent/SI2187741T1/sl unknown
- 2008-08-14 EP EP12153605.6A patent/EP2450057B1/en active Active
- 2008-08-14 EP EP08795303A patent/EP2187741B1/en active Active
- 2008-08-14 CA CA2871864A patent/CA2871864C/en active Active
- 2008-08-14 HU HUE12153605A patent/HUE031866T2/en unknown
- 2008-08-14 NZ NZ583269A patent/NZ583269A/en unknown
- 2008-08-14 MX MX2010001628A patent/MX2010001628A/es active IP Right Grant
- 2008-08-14 PL PL08795303T patent/PL2187741T3/pl unknown
- 2008-08-14 DK DK08795303.0T patent/DK2187741T3/da active
- 2008-08-14 HR HRP20120350AT patent/HRP20120350T1/hr unknown
- 2008-08-14 AU AU2008287388A patent/AU2008287388B2/en active Active
- 2008-08-14 KR KR1020107005094A patent/KR101481764B1/ko active Active
- 2008-08-14 DK DK12153605.6T patent/DK2450057T3/en active
- 2008-08-14 SG SG2011094158A patent/SG177905A1/en unknown
- 2008-08-14 PT PT121536056T patent/PT2450057T/pt unknown
- 2008-08-14 KR KR1020147002848A patent/KR101544766B1/ko active Active
- 2008-08-14 EA EA201070149A patent/EA018704B1/ru unknown
- 2008-08-14 ES ES08795303T patent/ES2382571T3/es active Active
- 2008-08-14 AT AT08795303T patent/ATE549035T1/de active
- 2008-08-14 TW TW102134576A patent/TWI486357B/zh active
- 2008-08-14 JP JP2010521031A patent/JP5005812B2/ja active Active
- 2008-08-14 PL PL12153605T patent/PL2450057T3/pl unknown
- 2008-08-14 CN CN2008801112346A patent/CN101820758B/zh active Active
- 2008-08-14 CL CL2008002417A patent/CL2008002417A1/es unknown
- 2008-08-14 CN CN201310016448.8A patent/CN103254267B/zh active Active
- 2008-08-14 PT PT08795303T patent/PT2187741E/pt unknown
- 2008-08-14 SG SG10201504650VA patent/SG10201504650VA/en unknown
- 2008-08-14 CA CA2696330A patent/CA2696330C/en active Active
- 2008-08-14 TW TW097130947A patent/TWI419899B/zh active
- 2008-08-14 AR ARP080103557A patent/AR073155A1/es unknown
- 2008-08-14 BR BRPI0815540A patent/BRPI0815540A8/pt not_active Application Discontinuation
- 2008-08-14 SI SI200831728A patent/SI2450057T1/sl unknown
- 2008-08-14 EA EA201370109A patent/EA023550B1/ru unknown
- 2008-08-14 ES ES12153605.6T patent/ES2602978T3/es active Active
- 2008-08-14 LT LTEP12153605.6T patent/LT2450057T/lt unknown
2010
- 2010-02-09 IL IL203824A patent/IL203824A/en active IP Right Grant
- 2010-02-12 ZA ZA201001066A patent/ZA201001066B/xx unknown
2011
- 2011-11-29 US US13/306,043 patent/US8309601B2/en active Active
2012
- 2012-05-23 JP JP2012117773A patent/JP2012188438A/ja active Pending
- 2012-06-13 CY CY20121100542T patent/CY1112864T1/el unknown
- 2012-06-29 US US13/537,583 patent/US8633243B2/en active Active
2015
- 2015-05-07 JP JP2015094538A patent/JP2015164939A/ja active Pending
2016
- 2016-11-15 HR HRP20161503TT patent/HRP20161503T1/hr unknown
- 2016-11-23 CY CY20161101205T patent/CY1118329T1/el unknown
2017
- 2017-03-27 IL IL251419A patent/IL251419A0/en unknown
- 2017-08-10 JP JP2017154939A patent/JP2018009001A/ja active Pending
2020
- 2020-03-25 AR ARP200100825A patent/AR119704A2/es unknown

Also Published As

Publication number	Publication date
US8088824B2 (en)	2012-01-03
AU2008287388A1 (en)	2009-02-19
JP2018009001A (ja)	2018-01-18
EA023550B1 (ru)	2016-06-30
EA018704B1 (ru)	2013-10-30
CN103254267A (zh)	2013-08-21
US20120071684A1 (en)	2012-03-22
PL2450057T3 (pl)	2017-02-28
SI2187741T1 (sl)	2012-07-31
IL251419A0 (en)	2017-05-29
ZA201001066B (en)	2010-10-27
ES2602978T3 (es)	2017-02-23
PT2187741E (pt)	2012-06-21
PT2450057T (pt)	2016-12-15
WO2009023232A1 (en)	2009-02-19
EA201370109A1 (ru)	2014-01-30
TW201402597A (zh)	2014-01-16
ES2382571T3 (es)	2012-06-11
CY1112864T1 (el)	2016-04-13
CA2871864A1 (en)	2009-02-19
TW200916476A (en)	2009-04-16
KR101544766B1 (ko)	2015-08-17
HUE031866T2 (en)	2017-08-28
JP5005812B2 (ja)	2012-08-22
SG177905A1 (en)	2012-02-28
BRPI0815540A2 (pt)	2014-09-30
AR073155A1 (es)	2010-10-20
CN101820758A (zh)	2010-09-01
EP2187741A1 (en)	2010-05-26
JP2012188438A (ja)	2012-10-04
JP2015164939A (ja)	2015-09-17
IL203824A (en)	2017-04-30
KR20140024063A (ko)	2014-02-27
CA2696330C (en)	2015-03-24
BRPI0815540A8 (pt)	2023-04-11
MX2010001628A (es)	2010-06-02
PL2187741T3 (pl)	2012-08-31
CA2696330A1 (en)	2009-02-19
DK2187741T3 (da)	2012-04-16
SI2450057T1 (sl)	2017-01-31
CN101820758B (zh)	2013-03-06
DK2450057T3 (en)	2016-12-19
HRP20120350T1 (hr)	2012-05-31
TWI486357B (zh)	2015-06-01
HK1143537A1 (en)	2011-01-07
KR20100056488A (ko)	2010-05-27
CA2871864C (en)	2016-05-17
AR119704A2 (es)	2022-01-05
CN103254267B (zh)	2016-03-16
US20120330050A1 (en)	2012-12-27
US8633243B2 (en)	2014-01-21
AU2008287388B2 (en)	2014-11-06
CY1118329T1 (el)	2017-06-28
KR101481764B1 (ko)	2015-01-13
US20090048204A1 (en)	2009-02-19
NZ583269A (en)	2012-03-30
EP2450057B1 (en)	2016-09-28
TWI419899B (zh)	2013-12-21
SG10201504650VA (en)	2015-07-30
EP2187741B1 (en)	2012-03-14
EA201070149A1 (ru)	2010-08-30
EP2450057A1 (en)	2012-05-09
HRP20161503T1 (hr)	2017-01-13
ATE549035T1 (de)	2012-03-15
EP2187741A4 (en)	2010-08-25
CL2008002417A1 (es)	2009-03-27
US8309601B2 (en)	2012-11-13
JP2010536754A (ja)	2010-12-02

Publication	Publication Date	Title
SG10201504650VA (en)	2015-07-30	Novel Forms Of CDDO Methyl Ester
PL3296284T3 (pl)	2022-06-13	Nieterapeutyczne zastosowanie estru hydroksymaślanowego
IL234285B (en)	2018-04-30	A process for the preparation of boronate ester compounds and their intermediates
EP2250185A4 (en)	2011-11-16	NEW LUPANDERIVATE
ZA201006252B (en)	2011-06-29	Preparation of lenalidomide
EP2282755A4 (en)	2015-06-17	INHIBITION OF ANGIOGENESIS
IL212119A0 (en)	2011-06-30	Alkylcyclohexylethers of dihydrotetraazabenzoazulenes
EP2231687A4 (en)	2012-11-14	NEW DERIVATIVES OF ACYL-CYANPYRROLIDINES
PL2133419T3 (pl)	2019-02-28	Zastosowania beta-dipeptydów cyjanoficyny
GB0810219D0 (en)	2008-07-09	Masonary bracket
IL211052A0 (en)	2011-04-28	Synthesis of glatiramer acetate
PL2171061T3 (pl)	2019-03-29	Preparat esterazy
ZA201006228B (en)	2011-11-30	Combined use of cholestanol derivative
PL2278890T3 (pl)	2015-05-29	Kompozycje fitosteroli o zwiększonej dostępności biologicznej
GB201114396D0 (en)	2011-10-05	Location of basesation
EP2331490A4 (en)	2012-09-26	PREPARATION OF DIBUTOXYMETHANE
IL206021A0 (en)	2010-11-30	Crystalline form of azelastine
GB2460350B (en)	2011-04-06	Intermediates for the preparation of bile acids
PL384673A1 (pl)	2009-09-14	Zestaw podokładzinowych listew dekoracyjnych
GB0809256D0 (en)	2008-06-25	Hollow wall fixing
PL386302A1 (pl)	2010-04-26	Nowa pochodna izotiazolopirydyny
GB0811883D0 (en)	2008-07-30	Preparation of glycoside esters
GB0708898D0 (en)	2007-06-20	Preparation of glycoside esters
GB0821710D0 (en)	2008-12-31	Derivatives of dihydroindolone
TWM311768U (en)	2007-05-11	Improved structure of A-ladder